Vincristine Pfizer, Injektionslösung

7680536400609 CH-53640 Injektionslösung
Vincristine Pfizer, Injektionslösung
Vincristine Pfizer, Injektionslösung
Vincristine Pfizer, Injektionslösung
1 / 3
google

Article details

Package size
5 x 2 mg/2 mL
Selling units
5
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
vincristini sulfas
1.0 MG Substance Wirkstoff (Principe actif)
mannitolum
- Substance HNIDK
acidum sulfuricum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
0.0138 MG Substance HBESI

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
53640
Drug name
Vincristine Pfizer, Injektionslösung
Galenic form
LSINJ
ATC Code
L01CA02
Authorization status
Z
Dispensing category
A
First authorization
10/09/1996
Authorization expiration date
30/09/2026
IT Number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum

Package details

Description (FR)
VINCRISTINE Pfizer 2 mg/2ml 5 flac 2 ml
Description (DE)
VINCRISTINE Pfizer 2 mg/2ml 5 Durchstf 2 ml
Market launch
10/09/1996
Market withdrawal
30/09/2026
Narcotic (BTM)
No

Available generics (2)

Vincristin Teva, Injektionslösung
GTIN: 7680480001006
CHF 29.20
View
Vincristin Teva, Injektionslösung
GTIN: 7680480001013
CHF 38.30
View

Other package sizes (2)

VINCRISTINE Pfizer 1 mg/ml 5 flac 1 ml
5 x 1 mg/1 mL DUR
GTIN: 7680536400524
View
None
None None
GTIN: None
Not in V1
Buy us a coffee Explore the data